Global Biologics And Biosimilars Industry 2015 Deep Market Research Report

Global Biologics And Biosimilars Industry 2015 Deep Market Research Report

Category : Pharmaceuticals
Published On : March  2015
Pages : 170



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Global Biologics And Biosimilars Industry 2015 Deep Market Research Report is a professional and depth research report on Global Biologics and Biosimilars industry.

For overview analysis, the report introduces Biologics and Biosimilars basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.For international and China market analysis, the report analyzes Biologics and Biosimilars markets in China and other countries or regions (such as Asia, Europe, North America etc) by presenting research on global products of different types and applications, developments and trends of market, technology, and competitive landscape, and leading suppliers and countries’ 2010-2015 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as production value, customers, application, market position, and company contact information, etc. 2016-2021 forecast on production value for these markets are also included.

For technical data and manufacturing plants analysis, the report analyzes Biologics and Biosimilars leading suppliers on commercial production value, manufacturing plants distribution, R&D Status, technology sources, and raw materials sources.

This report also presents product specification, manufacturing process, and product value etc. Production is separated by regions, technology and applications. Analysis also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals.In the end, the report includes Biologics and Biosimilars new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis. 

In conclusion, it is a deep research report on Global Biologics and Biosimilars industry. Here, we express our thanks for the support and assistance from Biologics and Biosimilars industry chain related technical experts and marketing engineers during Research Team’s survey and interviews.

Chapter One Biologics and Biosimilars Industry Overview  1

1.1 Biologics and Biosimilars Definition      1

1.2 Biologics and Biosimilars Classification and Application      5

1.3 Biologics and Biosimilars Industry Chain Structure      7

1.4 Biologics and Biosimilars Industry Overview 7

1.5 Biologics and Biosimilars Industry Policy Analysis       8

1.6 Biologics and Biosimilars Industry News Analysis 9



Chapter Two Biologics and Biosimilars International and China Market Analysis      11

2.1 Biologics and Biosimilars Industry International Market Analysis 11

2.1.1 Biologics and Biosimilars International Market Development History      11

2.1.2 Biologics and Biosimilars Product and Technology Developments    12

2.1.3 Biologics and Biosimilars Competitive Landscape Analysis       14

2.1.4 Biologics and Biosimilars International Key Countries Development Status     15

2.1.5 Biologics and Biosimilars International Market Development Trend  16

2.2 Biologics and Biosimilars Industry China Market Analysis    17

2.2.1 Biologics and Biosimilars China Market Development History  17

2.2.2 Biologics and Biosimilars Product and Technology Developments    18

2.2.3 Biologics and Biosimilars Competitive Landscape Analysis       20



Chapter Three Biologics and Biosimilars Technical Data Analysis      21

3.1 2010-2015E Global Key Manufacturers Biologics Revenue Structure Analysis    21

3.2 2010-2015E Global Key Manufacturers Biosimilars Revenue Structure Analysis 21



Chapter Four Biologics and Biosimilars Patent Analysis      23

4.1 2013 Global Top Ten Biosimilars Products Sales Analysis     23

4.2 Biological Medicines with Patents about to expire or expired       24 



Chapter Five Biologics and Biosimilars Manufacturing Process and Cost Structure   24

5.1 Biologics and Biosimilars Product Specifications   24

5.2 Biologics and Biosimilars Manufacturing Process Analysis   26

5.3 Biologics and Biosimilars Marketing Process Analysis   28

5.4 Biologics and Biosimilars Approval Process Analysis    28

5.5 Biologics and Biosimilars Cost Structure Analysis 29

5.6 Biologics and Biosimilars Price Analysis       30 



Chapter Six 2010-2015E Biologics and Biosimilars Productions Supply Sales Demand Market Status    30

6.1 2010-2015E Biologics Industry Overview     30

6.2 2010-2015E Biosimilars Industry Overview   40



Chapter Seven Biologics and Biosimilar Major Manufacturers Analysis     46

Biologics 46

7.1 Pfizer       46

7.1.1 Company Profile   47

7.1.2 Sales (Million $) Sales growth rate     50

7.1.3 Contact Information     51

7.2 Roche       51

7.2.1 Company Profile   51

7.2.2 Sales (Million $) Sales growth rate     53

7.2.3 Contact Information     54

7.3 Amgen      54

7.3.1 Company Profile   54

7.3.2 Sales (Million $) Sales growth rate     56

7.3.3 Contact Information     57

7.4 AbbVie     58

7.4.1 Company Profile   58

7.4.2 Sales (Million $) Sales growth rate     59

7.4.3 Contact Information     60

7.5 Sanofi      60

7.5.1 Company Profile   61

7.5.2 Sales (Million $) Sales growth rate     64

7.5.3 Contact Information     65

7.6 Johnson & Johnson  65

7.6.1 Company Profile   65

7.6.2 Sales (Million $) Sales growth rate     67

7.6.3 Contact Information     68

7.7 Novo Nordisk   68

7.7.1 Company Profile   69

7.7.2 Sales (Million $) Sales growth rate     70

7.7.3 Contact Information     71

7.8 Novartis    71

7.8.1 Company Profile   72

7.8.2 Sales (Million $) Sales growth rate     73

7.8.3 Contact Information     74

7.9 Merck       75

7.9.1 Company Profile   75

7.9.2 Sales (Million $) Sales growth rate     77

7.9.3 Contact Information     78

7.10 Lilly       79

7.10.1 Company Profile 79

7.10.2 Sales (Million $) Sales growth rate    81

7.10.3 Contact Information   82

7.11 3sbio       83

7.11.1 Company Profile 83

7.11.2 Sales (Million $) Sales growth rate    84

7.11.3 Contact Information    85

7.12 Changchun High and New Technology Industry (Group) Inc.     86

7.12.1 Company Profile 86

7.12.2 Sales (Million $) Sales growth rate    86

7.12.3 Contact Information   87

7.13 CP Guojian Pharmacy    88

7.13.1 Company Profile 88

7.13.2 Sales (Million $) Sales growth rate    88

7.13.3 Contact Information   89

7.14 Biotech Pharma     89

7.1.1 Company Profile   89

7.14.2 Sales (Million $) Sales growth rate    90

7.14.3 Contact Information   91

7.15 Gelgen Biopharma 91

7.15.1 Company Profile 92

7.15.2 Sales (Million $) Sales growth rate    93

7.15.3 Contact Information   94

Biosimilar      95

7.1 SANDOZ (NOVARTIS)  95

7.1.1 Company Profile   95

7.1.2 Sales (Million $) Sales growth rate     96

7.1.3 Contact Information     97

7.2 Teva Pharmaceutical Industries       98

7.2.1 Company Profile   98

7.2.2 Sales (Million $) Sales growth rate     99

7.2.3 Contact Information     100

7.3 Hospira (Pfizer) 100

7.3.1 Company Profile   100

7.3.2 Sales (Million $) Sales growth rate     101

7.1.3 Contact Information     102

7.4 MYLAN INC.  102

7.4.1 Company Profile   102

7.4.2 Sales (Million $) Sales growth rate     103

7.4.3 Contact Information     104

7.5 3sbio 105

7.5.1 Company Profile   105

7.5.2 Sales (Million $) Sales growth rate     106

7.5.3 Contact Information     107

7.6 Changchun High and New Technology Industry (Group) Inc.      108

7.6.1 Company Profile   108

7.6.2 Sales (Million $) Sales growth rate     108

7.6.3 Contact Information     109

7.7 CP Guojian Pharmacy     110

7.7.1 Company Profile   110

7.7.2 Sales (Million $) Sales growth rate     110

7.7.3 Contact Information     111

7.8 Biotech Pharma       111

7.8.1 Company Profile   111

7.8.2 Sales (Million $) Sales growth rate     112

7.8.3 Contact Information     113

7.9 Gelgen Biopharma   113

7.9.1 Company Profile   114

7.9.2 Sales (Million $) Sales growth rate     115

7.9.3 Contact Information     116 



Chapter Eight Biologics and Biosimilars Industry Chain Structure Analysis      117

8.1 Biologics Segment Market Analyses       117

8.2 Biologics and Biosimilars Industry Development in Emerging Markets       118

8.3 Key Applications and Consumption Analysis  119

8.4 Key Regions and Consumption Analysis 121



Chapter Nine Biologics and Biosimilars Marketing Channels Analysis       123

9.1 Biologics and Biosimilars Marketing Channels Status    123

9.2 Biologics and Biosimilars Marketing Channels Characteristic       124

9.3 Biologics and Biosimilars Marketing Channels Development Trend     125



Chapter Ten 2015E-2021 Biologics and Biosimilars Productions Supply Sales Demand Market Status and Forecast      128

10.1 2015E-2021 Biologics Market Status and Forecast      128

10.2 2015E-2021 Biosimilars Market Status and Forecast   129 



Chapter Eleven Paclitaxel Industry Development Proposals 131

11.1 Macroeconomic Development Countermeasures   131

11.1.1 Specific control measures   133

11.1.2 Key success factors between Mature Countries and Emerging Countries  135

11.1.3 Macroeconomic policy       136

11.2 New Firms Enter Market Strategy 137

11.3 New Project Investment Proposals 140

11.4 Competitive Environment Strategy Proposals      141



Chapter Twelve Biologics and Biosimilars New Project Investment Feasibility Analysis   142

12.1 Biologics and Biosimilars Project SWOT Analysis      142

12.2 Biologics and Biosimilars Project PEST Analysis 142

12.2.1 Political Factors  142

12.2.2 Economic Factors       143

12.2.3 Sociocultural Factors  153

12.2.4 Technological Factors 154



Chapter Thirteen Global Biologics and Biosimilars Industry Research Conclusions   155



Tables and Figures

 

Figure Biologics and Biosimilars Product Picture 1

Figure Biologics Product Picture   2

Figure Biosimilars Product Picture       2

Table Difference between biologics and biosimilar:     3

Table Biosimilars Classification and Application List   5

Figure Biologics and Biosimilars Industry Chain Structure  7

Figure 2014 Global FOB Policy and Regulations 9

Table Global Major Generic Companies Active in FOB Development List  12

Table 2012-2016 Patent Expirations Brand in US, Japan, UK, France and Germany 12

Figure 2014 Global Major Manufacturers Biologics Sales Market Share    14

Figure 2014 Global Major Manufacturers Biosimilars Sales Market Share 15

Figure 2014 Global Major Countries Biologics Sales Market Share    15

Figure 2014 Global Major Countries Biosimilars Sales Market Share 16

Figure 2015-2020 Global Biologics Sales and Growth Rate 16

Figure 2015-2020 Global Biosimilars Sales and Growth Rate     17

Figure 2010-2014 China Number of New Drugs Approved 18

Figure Innovation Fund Invested on Biologics Industry Trend    19

Figure 2014 China Major Manufacturers Biologics Sales Market Share     20

Figure 2014 China Major Manufacturers Biosimilars Sales Market Share   20

Table 2010-2015E Global Key Manufacturers Biologics Proportion of Revenues List       21

Table 2010-2015E Global Key Manufacturers Biosimilars Proportion of Revenues List    21

Table 2013 Global Top Ten Biosimilars Products Sales (billion USD) List 23

Table Biological Medicines with Patents about to expire or expire List      24

Table Difference of Specifications between Original Chemical Drugs and Biologics List  25

Table Difference of Specifications among Original Biologics, Biosimilars and Chemical Generics List    26

Figure Biologics and Biosimilars Marketing Process    28

Figure 2014 Biologics and Biosimilars Cost Structure List  29

Table 2010-2015E Global Major Manufacturers Biologics Sales and Total Sales List 30

Table 2010-2015E Global Major Manufacturers Biologics Sales Market Share List   31

Figure 2010 Global Major Manufacturers Biologics Sales Market Share    32

Figure 2011 Global Major Manufacturers Biologics Sales Market Share    33

Figure 2012 Global Major Manufacturers Biologics Sales Market Share    34

Figure 2013 Global Major Manufacturers Biologics Sales Market Share    35

Figure 2014 Global Major Manufacturers Biologics Sales Market Share    36

Table 2010-2015E China Major Manufacturers Biologics Sales and Total Sales List  36

Table 2010-2015E China Major Manufacturers Biologics Sales and Total Sales Market Share List   37

Figure 2010 China Major Manufacturers Biologics Sales Market Share     37

Figure 2011 China Major Manufacturers Biologics Sales Market Share      38

Figure 2012 China Major Manufacturers Biologics Sales Market Share     38

Figure 2013 China Major Manufacturers Biologics Sales Market Share     39

Figure 2014 China Major Manufacturers Biologics Sales Market Share     39

Table 2010-2015E Global Major Manufacturers Biosimilars Sales and Total Sales List     40

Table 2010-2015E Global Major Manufacturers Biosimilars Sales Market Share List       40

Figure 2010 Global Major Manufacturers Biosimilars Sales Market Share 41

Figure 2011 Global Major Manufacturers Biosimilars Sales Market Share  41

Figure 2012 Global Major Manufacturers Biosimilars Sales Market Share 42

Figure 2013 Global Major Manufacturers Biosimilars Sales Market Share 42

Figure 2014 Global Major Manufacturers Biosimilars Sales Market Share 43

Table 2010-2015E China Major Manufacturers Biosimilars Sales and Total Sales List      43

Table 2010-2015E China Major Manufacturers Biosimilars Sales and Total Sales Market Share List       43

Figure 2010 China Major Manufacturers Biosimilars Sales Market Share   44

Figure 2011 China Major Manufacturers Biosimilars Sales Market Share   44

Figure 2012 China Major Manufacturers Biosimilars Sales Market Share   45

Figure 2013 China Major Manufacturers Biosimilars Sales Market Share   45

Figure 2014 China Major Manufacturers Biosimilars Sales Market Share   46

Table 2010-2015E Pfizer Biologics Sales (Million $) and Growth Rate     50

Figure 2010-2015E Pfizer Biologics Sales (Million $) and Growth Rate    50

Figure 2010-2015E Pfizer Biologics Sales (Million $) and Global Market Share      50

Table 2010-2015E Roche Biologics Sales (Million $) and Growth Rate     53

Figure 2010-2015E Roche Biologics Sales (Million $) and Growth Rate   53

Figure 2010-2015E Roche Biologics Sales (Million $) and Global Market Share      54

Table 2010-2015E Amgen Biologics Sales (Million $) and Growth Rate    56

Figure 2010-2015E Amgen Biologics Sales (Million $) and Growth Rate  57

Figure 2010-2015E Amgen Biologics Sales (Million $) and Global Market Share     57

Table 2010-2015E AbbVie Biologics Sales (Million $) and Growth Rate   59

Figure 2010-2015E AbbVie Biologics Sales (Million $) and Growth Rate  59

Figure 2010-2015E AbbVie Biologics Sales (Million $) and Global Market Share    60

Table 2010-2015E Sanofi Biologics Sales (Million $) and Growth Rate     64

Figure 2010-2015E Sanofi Biologics Sales (Million $) and Growth Rate   64

Figure 2010-2015E Sanofi Biologics Sales (Million $) and Global Market Share     64

Table 2010-2015E Johnson & Johnson Biologics Sales (Million $) and Growth Rate       67

Figure 2010-2015E Johnson & Johnson Biologics Sales (Million $) and Growth Rate     67

Figure 2010-2015E Johnson & Johnson Biologics Sales (Million $) and Global Market Share 68

Table 2010-2015E Novo Nordisk Biologics Sales (Million $) and Growth Rate 70

Figure 2010-2015E Novo Nordisk Biologics Sales (Million $) and Growth Rate      70

Figure 2010-2015E Novo Nordisk Biologics Sales (Million $) and Global Market Share  71

Table 2010-2015E Novartis Biologics Sales (Million $) and Growth Rate  73

Figure 2010-2015E Novartis Biologics Sales (Million $) and Growth Rate       74

Figure 2010-2015E Novartis Biologics Sales (Million $) and Global Market Share   74

Table 2010-2015E Merck Biologics Sales (Million $) and Growth Rate     77

Figure 2010-2015E Merck Biologics Sales (Million $) and Growth Rate   78

Figure 2010-2015E Merck Biologics Sales (Million $) and Global Market Share      78

Table 2010-2015E Lilly Biologics Sales (Million $) and Growth Rate       81

Figure 2010-2015E Lilly Biologics Sales (Million $) and Growth Rate     82

Figure 2010-2015E Lilly Biologics Sales (Million $) and Global Market Share 82

Table 2010-2015E 3sbio Biologics Sales (Million $) and Growth Rate      84

Figure 2010-2015E 3sbio Biologics Sales (Million $) and Growth Rate     85

Figure 2010-2015E 3sbio Biologics Sales (Million $) and Global Market Share       85

Table 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biologics Sales (Million $) and Growth Rate       86

Figure 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biologics Sales (Million $) and Growth Rate     87

Figure 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biologics Sales (Million $) and Global Market Share       87

Table 2010-2015 CP Guojian Pharmacy Biologics Sales (Million $) and Growth Rate      88

Figure 2010-2015 CP Guojian Pharmacy Biologics Sales (Million $) and Growth Rate    88

Figure 2010-2015 CP Guojian Pharmacy Biologics Sales (Million $) and Global Market Share       89

Table 2010-2015 Biotech Pharma Biologics Sales (Million $) and Growth Rate 90

Figure 2010-2015 Biotech Pharma Biologics Sales (Million $) and Growth Rate      90

Figure 2010-2015 Biotech Pharma Biologics Sales (Million $) and Global Market Share 91

Table 2010-2015E Gelgen Biopharma Biologics Sales (Million $) and Growth Rate 93

Figure 2010-2015E Gelgen Biopharma Biologics Sales (Million $) and Growth Rate       94

Figure 2010-2015E Gelgen Biopharma Biologics Sales (Million $) and Global Market Share  94

Table 2010-2015 SANDOZ (NOVARTIS) Biosimilar Sales (Million $) and Growth Rate 96

Figure 2010-2015 SANDOZ (NOVARTIS) Biosimilar Sales (Million $) and Growth Rate       97

Figure 2010-2015 SANDOZ (NOVARTIS) Biosimilar Sales (Million $) and Global Market Share  97

Table 2010-2015 Teva Pharmaceutical Industries Biosimilar Sales (Million $) and Growth Rate      99

Figure 2010-2015 Teva Pharmaceutical Industries Biosimilar Sales (Million $) and Growth Rate    99

Figure 2010-2015 Teva Pharmaceutical Industries Biosimilar Sales (Million $) and Global Market Share       100

Table 2010-2015 Pfizer Biosimilar Sales (Million $) and Growth Rate      101

Figure 2010-2015 Pfizer Biosimilar Sales (Million $) and Growth Rate    101

Figure 2010-2015 Pfizer Biosimilar Sales (Million $) and Global Market Share       102

Table 2010-2015 MYLAN INC. Biosimilar Sales (Million $) and Growth Rate 103

Figure 2010-2015 MYLAN INC. Biosimilar Sales (Million $) and Growth Rate      104

Figure 2010-2015 MYLAN INC. Biosimilar Sales (Million $) and Global Market Share  104

Table 2010-2015E 3sbio Biosimilar Sales (Million $) and Growth Rate     106

Figure 2010-2015E 3sbio Biosimilar Sales (Million $) and Growth Rate   107

Figure 2010-2015E 3sbio Biosimilar Sales (Million $) and Global Market Share      107

Table 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biosimilar Sales (Million $) and Growth Rate       108

Figure 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biosimilar Sales (Million $) and Growth Rate       109

Figure 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biosimilar Sales (Million $) and Global Market Share       109

Table 2010-2015 CP Guojian Pharmacy Biosimilar Sales (Million $) and Growth Rate    110

Figure 2010-2015 CP Guojian Pharmacy Biosimilar Sales (Million $) and Growth Rate   110

Figure 2010-2015 CP Guojian Pharmacy Biosimilar Sales (Million $) and Global Market Share     111

Table 2010-2015 Biotech Pharma Biosimilar Sales (Million $) and Growth Rate      112

Figure 2010-2015 Biotech Pharma Biosimilar Sales (Million $) and Growth Rate    112

Figure 2010-2015 Biotech Pharma Biosimilar Sales (Million $) and Global Market Share       113

Table 2010-2015E Gelgen Biopharma Biosimilar Sales (Million $) and Growth Rate       115

Figure 2010-2015E Gelgen Biopharma Biosimilar Sales (Million $) and Growth Rate     116

Figure 2010-2015E Gelgen Biopharma Biosimilar Sales (Million $) and Global Market Share 116

Figure Biologics Global Market Share and Share of Biologics by Sales     117

Figure Spending on Biologics in Emerging Markets    118

Figure Recombinant Protein Production in Emerging Markets    119

Table 2014 China Infective Population of Several Diseases 119

Figure 2014 Global Biologics in Research Statistics by Indications    120

Figure the biologics with more than 1Bn USD by country  120

Figure Data exclusivity period      121

Figure 2014 Global Biologics Consumption Market Share by Regions       121

Figure 2014 Global Biosimilars Consumption Market Share by Regions    121

Table 2003, 2008 and 2013 Global Pharmaceutical Market Scale Ranking 121

Figure Beset sales biologics patent 122

Figure Biologics and Biosimilars Domestic Marketing Channels Status      123

Figure Imported Biologics and Biosimilars Marketing Channels Status      124

Figure 4 P’ S Marketing model     126

Figure 7 P’ S Marketing model     127

Table 2015E-2021 Global Biologics Sales (Million $) and Growth Rate    128

Figure 2015E-2021 Global Biologics Sales and Growth Rate     128

Table 2015E-2021 China Biologics Sales (Million $) and Growth Rate      128

Figure 2015E-2021 China Biologics Sales and Growth Rate       129

Table 2015E-2021 Global Biosimilars Sales (Million $) and Growth Rate  129

Figure 2015E-2021 Global Biosimilars Sales and Growth Rate   130

Table 2015E-2021 China Biosimilars Sales (Million $) and Growth Rate   130

Figure 2015E-2021 China Biosimilars Sales and Growth Rate    130

Figure Health and Care Industry market trend in China      132

Figure characteristics that influence the background of Health and Care Industry market in China   133

Table factors vary according to the level of economic development    135

Table New Firms Enter Market Strategy      137

Figure administration on start up   139

Figure Share of GDP according to the size of the companies      140

Table New Project Investment Proposals      140

Figure European private equity funds raised in 2010   141

Table Competitive Environment Strategy Proposals     141

Table Biologics and Biosimilars New Project SWOT Analysis for Chinese Company 142

Figure 2007-2013 China GDP (100 million RMB) and Growth Rate  143

Figure 2007-2013 China CPI Change Trend 144

Figure 2007-2013 China Urban and Rural Incomes (RMB) 145

Figure 2007-2013 China Total Retail Sales of Consumer Goods (100 million RMB) and Growth Rate    146

Figure 2007-2013 China Investment in Fixed Assets (100 million RMB) and Growth Rate      147

Figure 2007-2013 China the Total Value of Imports and Exports of Goods (100 million USD) and Growth Rate   148

Table 2014 China Macroeconomic Forecast Key Indicators (%)  149

Figure 2007-2013 EU27 GDP Growth Rate  149

Figure 2007-2013 EU27 HICP Index (The month of year-on-year)    150

Figure 2007-2013 United States GDP (100 million USD)   150

Figure 2007-2013 United States CPI    151

Figure 2007-2013 Japan GDP (Billion Yen) 151

Figure 2007-2013 Japan CPI (The month of year-on-year) 152

Figure 1993-2013 Global Incidences of Malignant Tumors 154

Figure the amount of biosimilar in research  155


Enquiry Before Buy
image
Can´t read the image ? refresh here.